-
公开(公告)号:US20210371525A1
公开(公告)日:2021-12-02
申请号:US17277984
申请日:2019-09-19
Applicant: LAVA THERAPEUTICS B.V.
Inventor: Iris DE WEERDT , Arnon Philip KATER , Paul Willem Henri Ida PARREN , Tanja Denise DE GRUIJL , Johannes Jelle VAN DER VLIET , Roeland LAMERIS
Abstract: The present invention relates to novel methods for the treatment of hematological malignancies. In particular, the invention relates to the treatment of hematological malignancies using antibodies comprising a first binding moiety that is able to bind human CD1d and a second binding moiety that is able to bind the human Vγ9Vδ2-TCR.